FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma

Go back to FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 55.30 +1.15 (2.12%)
Previous Close $54.15    52 Week High $35.13 
Open $55.13    52 Week Low $28.10 
Day High $55.59    P/E N/A 
Day Low $55.05    EPS $0.00 
Volume 1,379,117       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 365.40 -7.34 (1.97%)
Previous Close $372.74    52 Week High $195.93 
Open $372.00    52 Week Low $155.79 
Day High $374.15    P/E 68.04 
Day Low $364.33    EPS $5.37 
Volume 1,030,926